Cargando…
Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A
Acute myeloid leukemia (AML) is an aggressive hematological malignancy occurring very often in older adults, with poor prognosis depending on both rapid disease progression and drug resistance occurrence. Therefore, new therapeutic approaches are demanded. Epigenetic marks play a relevant role in AM...
Autores principales: | Illiano, Michela, Conte, Mariarosaria, Sapio, Luigi, Nebbioso, Angela, Spina, Annamaria, Altucci, Lucia, Naviglio, Silvio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063003/ https://www.ncbi.nlm.nih.gov/pubmed/30079022 http://dx.doi.org/10.3389/fphar.2018.00792 |
Ejemplares similares
-
The KDM Inhibitor GSKJ4 Triggers CREB Downregulation via a Protein Kinase A and Proteasome-Dependent Mechanism in Human Acute Myeloid Leukemia Cells
por: Illiano, Michela, et al.
Publicado: (2020) -
Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells
por: Sapio, Luigi, et al.
Publicado: (2015) -
The Influence of the Polymer Amount on the Biological Properties of PCL/ZrO(2) Hybrid Materials Synthesized via Sol-Gel Technique
por: Catauro, Michelina, et al.
Publicado: (2017) -
Targeting CREB in Cancer Therapy: A Key Candidate or One of Many? An Update
por: Sapio, Luigi, et al.
Publicado: (2020) -
Targeting protein kinase A in cancer therapy: an update
por: Sapio, Luigi, et al.
Publicado: (2014)